Literature DB >> 15376207

Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury.

G K Glantzounis1, W Yang, R S Koti, D P Mikhailidis, A M Seifalian, B R Davidson.   

Abstract

BACKGROUND: N-acetylcysteine (NAC) may modulate the initial phase (less than 2 h) of liver warm ischaemia-reperfusion (IR) injury but its effect on the late phase remains unclear. The present study investigated the role of NAC during the early and late phases in a rabbit lobar IR model.
METHODS: Liver ischaemia was induced by inflow occlusion to the median and left liver lobes for 60 min, followed by 7 h of reperfusion. In the NAC group (n = 6), NAC was administered intravenously at 150 mg per kg over the 15 min before reperfusion and maintained at 10 mg per kg per h during reperfusion. In the IR group (n = 6), 20 ml 5 per cent dextrose was infused over the 15 min before reperfusion and continued at a rate of 10 ml/h. Animals in a sham operation group (n = 6) underwent laparotomy but no liver ischaemia. All animals were killed at the end of the experiment.
RESULTS: Intracellular tissue oxygenation was improved after the second hour of reperfusion in animals treated with NAC compared with that in the IR group (P = 0.023). Hepatic microcirculation improved after 5 h of reperfusion (P = 0.036) and liver injury was reduced after 5 h, as indicated by alanine aminotransferase activity (P = 0.007) and indocyanine green clearance (uptake, P = 0.001; excretion, P = 0.032).
CONCLUSION: The main protective effect of NAC becomes apparent 5 h after hepatic ischaemic injury. Copyright (c) 2004 British Journal of Surgery Society Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15376207     DOI: 10.1002/bjs.4694

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

Review 1.  Current protective strategies in liver surgery.

Authors:  Kurinchi S Gurusamy; Hector D Gonzalez; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  N-acetylcysteine -- passe-partout or much ado about nothing?

Authors:  Mirja-Liisa Aitio
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

3.  Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection.

Authors:  Oleg Heizmann; Georgios Meimarakis; Andreas Volk; Daniel Matz; Daniel Oertli; Rolf J Schauer
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

4.  Ischemic preconditioning attenuates lactate release by the liver during hepatectomies under vascular control: a case-control study.

Authors:  Kassiani Theodoraki; Nikolaos Arkadopoulos; George Fragulidis; Ioannis Vassiliou; Maria Markatou; Agatha Pafiti; Georgia Kostopanagiotou; Vassilios Smyrniotis
Journal:  J Gastrointest Surg       Date:  2011-02-11       Impact factor: 3.452

5.  Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicity.

Authors:  Alessandra Milesi-Hallé; Susan M Abdel-Rahman; Aliza Brown; Sandra S McCullough; Lynda Letzig; Jack A Hinson; Laura P James
Journal:  Chem Biol Interact       Date:  2010-12-09       Impact factor: 5.192

Review 6.  Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-27       Impact factor: 2.192

Review 7.  Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery.

Authors:  Santhalingam Jegatheeswaran; Ajith K Siriwardena
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

8.  Description of a Recovery Model in Rabbits for the Study of the Late Phase of Liver Ischemia-Reperfusion Injury.

Authors:  Athina G Mantelou; Argyro Zacharioudaki; George Pappas-Gogos; Apostolos Papalois; Alexandra Papoudou-Bai; Anna Goussia; Georgios K Glantzounis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

9.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

10.  Effects of hyperbaric oxygen and N-acetylcysteine in survival of random pattern skin flaps in rats.

Authors:  Fernando P da Rocha; Djalma J Fagundes; Jefferson A Pires; Fernanda Salim T da Rocha
Journal:  Indian J Plast Surg       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.